As expected, methylation levels of ADCY4, CPXM1, DNM3, GNG4, MAST1, PRDM14, and ZNF177 were found to be increased in breast cancer, and all with p values lower than 0.001 (Fig. 4). Here, PRDM14 is linked to breast cancer.